2,927 Shares in Teleflex Incorporated (NYSE:TFX) Acquired by Twin Capital Management Inc.

Twin Capital Management Inc. acquired a new stake in shares of Teleflex Incorporated (NYSE:TFX) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 2,927 shares of the medical technology company’s stock, valued at approximately $521,000.

Other large investors have also bought and sold shares of the company. HighTower Advisors LLC increased its stake in Teleflex by 1.7% in the 3rd quarter. HighTower Advisors LLC now owns 3,998 shares of the medical technology company’s stock worth $986,000 after acquiring an additional 66 shares during the last quarter. Hengehold Capital Management LLC raised its stake in Teleflex by 7.3% in the fourth quarter. Hengehold Capital Management LLC now owns 1,289 shares of the medical technology company’s stock valued at $229,000 after purchasing an additional 88 shares in the last quarter. Exchange Traded Concepts LLC lifted its position in Teleflex by 38.2% during the fourth quarter. Exchange Traded Concepts LLC now owns 340 shares of the medical technology company’s stock valued at $61,000 after purchasing an additional 94 shares during the last quarter. Isthmus Partners LLC grew its stake in Teleflex by 7.3% in the 4th quarter. Isthmus Partners LLC now owns 1,535 shares of the medical technology company’s stock worth $273,000 after buying an additional 105 shares in the last quarter. Finally, Sumitomo Mitsui DS Asset Management Company Ltd raised its position in shares of Teleflex by 2.4% during the 4th quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 4,991 shares of the medical technology company’s stock valued at $888,000 after buying an additional 118 shares in the last quarter. 95.62% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

A number of research firms recently commented on TFX. Needham & Company LLC reissued a “hold” rating on shares of Teleflex in a research note on Wednesday, March 12th. Piper Sandler reissued a “neutral” rating and set a $140.00 price objective (down from $255.00) on shares of Teleflex in a report on Friday, February 28th. Raymond James cut shares of Teleflex from an “outperform” rating to a “market perform” rating in a research report on Friday, February 28th. Bank of America lowered shares of Teleflex from a “neutral” rating to an “underperform” rating and lowered their price objective for the stock from $235.00 to $140.00 in a report on Tuesday, March 4th. Finally, Morgan Stanley decreased their target price on shares of Teleflex from $275.00 to $191.00 and set an “overweight” rating on the stock in a research report on Wednesday, March 5th. One equities research analyst has rated the stock with a sell rating, nine have assigned a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat, Teleflex presently has a consensus rating of “Hold” and an average price target of $182.63.

Teleflex Trading Down 0.7 %

NYSE TFX opened at $130.95 on Tuesday. The company has a debt-to-equity ratio of 0.37, a quick ratio of 1.39 and a current ratio of 2.42. Teleflex Incorporated has a fifty-two week low of $127.18 and a fifty-two week high of $249.91. The stock has a market cap of $6.07 billion, a P/E ratio of 26.03, a price-to-earnings-growth ratio of 1.73 and a beta of 1.19. The stock has a 50 day simple moving average of $153.81 and a two-hundred day simple moving average of $185.45.

Teleflex (NYSE:TFX) last posted its earnings results on Thursday, February 27th. The medical technology company reported $3.89 EPS for the quarter, topping the consensus estimate of $3.86 by $0.03. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. The firm had revenue of $795.40 million during the quarter, compared to analysts’ expectations of $813.24 million. On average, analysts forecast that Teleflex Incorporated will post 13.98 earnings per share for the current year.

Teleflex Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Monday, March 17th. Investors of record on Friday, March 7th were given a dividend of $0.34 per share. The ex-dividend date of this dividend was Friday, March 7th. This represents a $1.36 dividend on an annualized basis and a yield of 1.04%. Teleflex’s dividend payout ratio (DPR) is currently 95.77%.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.